- £199.64m
- £193.10m
- £57.63m
Court Sanction of the Scheme
Satisfaction of Conditions
Holding(s) in Company
Holding(s) in Company
Offer Update
Brief: Instem Reaffirms It Considers Terms Of Archimed Offer To Be Fair And Reasonable
Statement regarding adjournment of the Meetings
Holding(s) in Company
Brief: Archimed Says Financial Terms Of Instem Deal Are Final
Holding(s) in Company
Offer Update and No Increase Statement
Brief: Instem Expects That Softer Market Conditions Referred To In H1 Results Will Continue At Least Into Fy24
Holding(s) in Company
Deals of the day-Mergers and acquisitions
Deals of the day-Mergers and acquisitions
Brief: BGF, Instem Shareholder, Says Does Not Agree With Recommendation Regarding Archimed Offer
Instem's second-largest shareholder opposes deal with PE firm Archimed
Holding(s) in Company
Publication of Scheme Document